Literature DB >> 12031692

Kinins, the long march--a personal view.

Ervin G Erdös.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12031692     DOI: 10.1016/s0008-6363(02)00284-5

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  9 in total

1.  Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients.

Authors:  Kevin E Chan; T Alp Ikizler; Jorge L Gamboa; Chang Yu; Raymond M Hakim; Nancy J Brown
Journal:  Kidney Int       Date:  2011-07-20       Impact factor: 10.612

2.  Interactions between carboxypeptidase M and kinin B1 receptor in endothelial cells.

Authors:  Paola Bianchi Guimarães; Rafael Filippelli da Silva; Carolina Caldas Hoff; Liliam Fernandes; Clovis Ryuichi Nakaie; Jair Ribeiro Chagas; Adriana Karaoglanovic Carmona; Michael Bader; João Bosco Pesquero
Journal:  Inflamm Res       Date:  2019-06-19       Impact factor: 4.575

3.  Endogenous bradykinin contributes to increased plasminogen activator inhibitor 1 antigen following hemodialysis.

Authors:  Annis M Marney; Ji Ma; James M Luther; T Alp Ikizler; Nancy J Brown
Journal:  J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 10.121

4.  Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition.

Authors:  Gary P Van Guilder; Mias Pretorius; James M Luther; J Brian Byrd; Kevin Hill; James V Gainer; Nancy J Brown
Journal:  Hypertension       Date:  2008-01-07       Impact factor: 10.190

Review 5.  Carboxypeptidase M augments kinin B1 receptor signaling by conformational crosstalk and enhances endothelial nitric oxide output.

Authors:  Xianming Zhang; Fulong Tan; Viktor Brovkovych; Yongkang Zhang; Jessica L Lowry; Randal A Skidgel
Journal:  Biol Chem       Date:  2013-03       Impact factor: 3.915

6.  Effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in dialysis patients: a nationwide data survey and propensity analysis.

Authors:  Cho-Kai Wu; Yao-Hsu Yang; Jyh-Ming Jimmy Juang; Yi-Chih Wang; Chia-Ti Tsai; Ling-Ping Lai; Juey-Jen Hwang; Fu-Tien Chiang; Pau-Chung Chen; Jiunn-Lee Lin; Lian-Yu Lin
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

Review 7.  Neprilysin Inhibitors and Bradykinin.

Authors:  Duncan J Campbell
Journal:  Front Med (Lausanne)       Date:  2018-09-19

8.  Pharmacological analysis of the rat femoral artery response to bradykinin.

Authors:  Miroslav Radenković; Marko Stojanović; Nebojša Skorupan; Milica Prostran
Journal:  Sci Pharm       Date:  2013-06-04

9.  Add-on Protective Effect of Pentoxifylline in Advanced Chronic Kidney Disease Treated with Renin-Angiotensin-Aldosterone System Blockade - A Nationwide Database Analysis.

Authors:  Ko-Lin Kuo; Szu-Chun Hung; Jia-Sin Liu; Yu-Kang Chang; Chih-Cheng Hsu; Der-Cherng Tarng
Journal:  Sci Rep       Date:  2015-11-27       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.